4 Amendments of Peter LIESE related to 2017/2254(INI)
Amendment 186 #
Calls on the European Commission to set up a specific EU Priority Pathogen List taking account the WHO list, which could be the basis for supporting the status of priority antibiotics and would provide a real added-value by directing R&D investments to the greatest threats;
Amendment 218 #
Motion for a resolution
Paragraph 10 – subparagraph 1 (new)
Paragraph 10 – subparagraph 1 (new)
Notes that the recently adopted EU indicators helping Member States to monitor their progress in combating AMR only focus on antibiotic consumption but do not reflect appropriateness of use; calls on the ECDC to amend the EU indicators accordingly;
Amendment 320 #
Motion for a resolution
Paragraph 15 a (new)
Paragraph 15 a (new)
15 a. Urges the European Commission to consider a new legislative framework to stimulate the development of new antimicrobials for humans, as already requested by the European Parliament on 10 March 2016 on the proposal for a regulation of the European Parliament and of the Council on veterinary medicinal products and in the parliamentary resolution (2015) 0197 of19 May 2015; notes that the Commission “One Health” Action Plan against AMR also commits itself to “analyse EU regulatory tools and incentives - in particular orphan and paediatric legislation – to use them for novel antimicrobials".
Amendment 394 #
Motion for a resolution
Paragraph 23 a (new)
Paragraph 23 a (new)
23 a. Calls for the use of transferable market exclusivities or market entry rewards to be considered as options for sustainable incentives;